HIMS - Hims & Hers Health, Inc. Stock Price, Fair Value and News

$21.80-1.73 (-7.35%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

HIMS Price Action

Last 7 days

-21.0%

Last 30 days

-5.4%

Last 90 days

32.4%

Trailing 12 Months

187.6%

HIMS RSI Chart

HIMS Valuation

Market Cap

4.7B

Price/Earnings (Trailing)

46.64

Price/Sales (Trailing)

3.8

EV/EBITDA

69.77

Price/Free Cashflow

25.29

HIMS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

HIMS Fundamentals

HIMS Revenue

Revenue (TTM)

1.2B

Rev. Growth (Yr)

77.13%

Rev. Growth (Qtr)

27.22%

HIMS Earnings

Earnings (TTM)

101.3M

Earnings Growth (Yr)

1.1K%

Earnings Growth (Qtr)

468.46%

HIMS Profitability

Operating Margin

81.13%

EBT Margin

4.16%

Return on Equity

23.01%

Return on Assets

16.81%

Free Cashflow Yield

3.95%

HIMS Investor Care

Shares Dilution (1Y)

3.85%

Diluted EPS (TTM)

0.44

HIMS Alerts

1 major insider buys and 6 major insider sales recently.
Big jump in Revenue (Y/Y)
Big jump in Earnings (Y/Y)

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	959.4M	1.1B	1.2B	0
2023	616.4M	710.7M	792.6M	872.0M
2022	320.9M	373.7M	444.4M	526.9M
2021	171.0M	195.8M	228.6M	271.9M
2020	99.1M	115.7M	132.2M	148.8M
2019	0	0	0	82.6M

Get all data in R, Python etc through our Historical Stock Data APIs

About Hims & Hers Health, Inc.

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.

CEO	Mr. Andrew Dudum
WEBSITE	forhims.com
SECTOR	Consumer Defensive
INDUSTRY	Household & Personal Products
EMPLOYEES	651

Hims & Hers Health, Inc. Frequently Asked Questions

What is the ticker symbol for Hims & Hers Health, Inc.? What does HIMS stand for in stocks?

HIMS is the stock ticker symbol of Hims & Hers Health, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Hims & Hers Health, Inc. (HIMS)?

As of Wed Nov 20 2024, market cap of Hims & Hers Health, Inc. is 4.72 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of HIMS stock?

You can check HIMS's fair value in chart for subscribers.

Is Hims & Hers Health, Inc. a good stock to buy?

The fair value guage provides a quick view whether HIMS is over valued or under valued. Whether Hims & Hers Health, Inc. is cheap or expensive depends on the assumptions which impact Hims & Hers Health, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HIMS.

What is Hims & Hers Health, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Nov 20 2024, HIMS's PE ratio (Price to Earnings) is 46.64 and Price to Sales (PS) ratio is 3.8. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HIMS PE ratio will change depending on the future growth rate expectations of investors.